{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T11:29:53Z","timestamp":1772623793900,"version":"3.50.1"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Innovative Medicine Initiative-Joint Undertaking","award":["115621"],"award-info":[{"award-number":["115621"]}]},{"DOI":"10.13039\/501100005743","name":"Universit\u00e0 Cattolica del Sacro Cuore","doi-asserted-by":"crossref","award":["D3.2 2013"],"award-info":[{"award-number":["D3.2 2013"]}],"id":[{"id":"10.13039\/501100005743","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005743","name":"Universit\u00e0 Cattolica del Sacro Cuore","doi-asserted-by":"crossref","award":["D3.2 2015"],"award-info":[{"award-number":["D3.2 2015"]}],"id":[{"id":"10.13039\/501100005743","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Centro Studi Achille e Linda Lorenzon"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Gerontology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.exger.2019.110766","type":"journal-article","created":{"date-parts":[[2019,10,27]],"date-time":"2019-10-27T02:05:17Z","timestamp":1572141917000},"page":"110766","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["Circulating amino acid signature in older people with Parkinson's disease: A metabolic complement to the EXosomes in PArkiNson Disease (EXPAND) study"],"prefix":"10.1016","volume":"128","author":[{"given":"Anna","family":"Picca","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Calvani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Landi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Marini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Biancolillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacopo","family":"Gervasoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Persichilli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aniello","family":"Primiano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Urbani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Bossola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Rita","family":"Bentivoglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Cesari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Landi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Bernabei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuele","family":"Marzetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Rita","family":"Lo Monaco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exger.2019.110766_bb0005","doi-asserted-by":"crossref","first-page":"259","DOI":"10.31887\/DCNS.2004.6.3\/galexander","article-title":"Biology of Parkinson\u2019s disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorder","volume":"6","author":"Alexander","year":"2004","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.exger.2019.110766_bb0010","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s10072-012-1112-z","article-title":"Validation of the Italian version of the Movement Disorder Society\u2014Unified Parkinson\u2019s Disease Rating Scale","volume":"34","author":"Antonini","year":"2013","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.exger.2019.110766_bb0015","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1074\/jbc.M208249200","article-title":"Cellular polyamines promote the aggregation of alpha-synuclein","volume":"278","author":"Antony","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.exger.2019.110766_bb0020","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/bpa.12370","article-title":"Alpha-synuclein as a biomarker for Parkinson\u2019s disease","volume":"26","author":"Atik","year":"2016","journal-title":"Brain Pathol."},{"key":"10.1016\/j.exger.2019.110766_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2019.06.005","article-title":"A breakdown in metabolic reprogramming causes microglia dysfunction in Alzheimer\u2019s disease","author":"Baik","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.exger.2019.110766_bb0030","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3389\/fneur.2019.00218","article-title":"Parkinson\u2019s disease and the environment","volume":"10","author":"Ball","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.exger.2019.110766_bb0035","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/mds.27581","article-title":"Unraveling gut microbiota in Parkinson's disease and atypical parkinsonism","volume":"34","author":"Barichella","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.exger.2019.110766_bb0040","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/cem.785","article-title":"Partial least squares for discrimination","volume":"17","author":"Barker","year":"2003","journal-title":"J. Chemom."},{"key":"10.1016\/j.exger.2019.110766_bb0045","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s11306-016-1094-6","article-title":"Metabolomics enables precision medicine: \u201cA White Paper, Community Perspective\u201d","volume":"12","author":"Beger","year":"2016","journal-title":"Metabolomics"},{"key":"10.1016\/j.exger.2019.110766_bb0050","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1091\/mbc.12.4.997","article-title":"Roles of phosphatidylethanolamine and of its several biosynthetic pathways in Saccharomyces cerevisiae","volume":"12","author":"Birner","year":"2001","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.exger.2019.110766_bb0055","doi-asserted-by":"crossref","first-page":"36827","DOI":"10.1074\/jbc.274.52.36827","article-title":"Lipid-assisted protein folding","volume":"274","author":"Bogdanov","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.exger.2019.110766_bb0060","doi-asserted-by":"crossref","first-page":"12339","DOI":"10.1074\/jbc.274.18.12339","article-title":"Phospholipid-assisted refolding of an integral membrane protein. Minimum structural features for phosphatidylethanolamine to act as a molecular chaperone","volume":"274","author":"Bogdanov","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.exger.2019.110766_bb0065","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.brainres.2010.03.111","article-title":"Relationships between large neutral amino acid levels in plasma, cerebrospinal fluid, brain microdialysate and brain tissue in the rat","volume":"1334","author":"Bongiovanni","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.exger.2019.110766_bb0070","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.exger.2013.10.010","article-title":"Fecal and urinary NMR-based metabolomics unveil an aging signature in mice","volume":"49","author":"Calvani","year":"2014","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.exger.2019.110766_bb0075","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3389\/fmed.2018.00053","article-title":"Of microbes and minds: a narrative review on the second brain aging","volume":"5","author":"Calvani","year":"2018","journal-title":"Front. Med."},{"key":"10.1016\/j.exger.2019.110766_bb0080","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.3390\/nu10111691","article-title":"A distinct pattern of circulating amino acids characterizes older persons with physical frailty and sarcopenia: results from the BIOSPHERE study","volume":"10","author":"Calvani","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.exger.2019.110766_bb0085","first-page":"1","article-title":"The importance of increased serum ornithine levels in the pathogenes\u0131s of Alzhe\u0131mer and Park\u0131nson\u2019s diseases","author":"\u00c7elik","year":"2018","journal-title":"Asian J. Res. Reports Neurol."},{"key":"10.1016\/j.exger.2019.110766_bb0175","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","article-title":"Epidemiology of Parkinson\u2019s disease","volume":"5","author":"de Lau","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.exger.2019.110766_bb0130","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/brain\/awg006","article-title":"Homocysteine and brain atrophy on MRI of non-demented elderly","volume":"126","author":"den Heijer","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.exger.2019.110766_bb0090","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s11011-009-9139-4","article-title":"Evidence that folic acid deficiency is a major determinant of hyperhomocysteinemia in Parkinson\u2019s disease","volume":"24","author":"dos Santos","year":"2009","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.exger.2019.110766_bb0095","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1046\/j.0022-3042.2001.00676.x","article-title":"Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson\u2019s disease","volume":"80","author":"Duan","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.exger.2019.110766_bb0100","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1016\/S0006-3495(96)79381-5","article-title":"Role of the position of unsaturation on the phase behavior and intrinsic curvature of phosphatidylethanolamines","volume":"71","author":"Epand","year":"1996","journal-title":"Biophys. J."},{"key":"10.1016\/j.exger.2019.110766_bb0105","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1023\/A:1013713905833","article-title":"Metabolomics\u2014the link between genotypes and phenotypes","volume":"48","author":"Fiehn","year":"2002","journal-title":"Plant Mol. Biol."},{"key":"10.1016\/j.exger.2019.110766_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191670","article-title":"Serum amino acid profile in patients with Parkinson's disease","volume":"13","author":"Figura","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.exger.2019.110766_bb0115","doi-asserted-by":"crossref","first-page":"6715","DOI":"10.1523\/JNEUROSCI.1594-04.2004","article-title":"Lipid rafts mediate the synaptic localization of alpha-synuclein","volume":"24","author":"Fortin","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.exger.2019.110766_bb0120","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1136\/jnnp-2014-309676","article-title":"Identification of novel biomarkers for Parkinson\u2019s disease by metabolomic technologies","volume":"87","author":"Hatano","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.exger.2019.110766_bb0125","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3390\/metabo7030042","article-title":"Biomarker research in Parkinson\u2019s disease using metabolite profiling","volume":"7","author":"Havelund","year":"2017","journal-title":"Metabolites"},{"key":"10.1016\/j.exger.2019.110766_bb0135","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nature06882","article-title":"Human metabolic phenotype diversity and its association with diet and blood pressure","volume":"453","author":"Holmes","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.exger.2019.110766_bb0140","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.exger.2019.110766_bb0145","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/35044114","article-title":"A ubiquitin-like system mediates protein lipidation","volume":"408","author":"Ichimura","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.exger.2019.110766_bb0150","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1097\/WNR.0b013e3282aaa0b4","article-title":"Homocysteine is toxic for dopaminergic neurons in primary mesencephalic culture","volume":"18","author":"Imamura","year":"2007","journal-title":"Neuroreport"},{"key":"10.1016\/j.exger.2019.110766_bb0155","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1016\/j.lfs.2005.02.014","article-title":"Increase of total homocysteine concentration in cerebrospinal fluid in patients with Alzheimer\u2019s disease and Parkinson\u2019s disease","volume":"77","author":"Isobe","year":"2005","journal-title":"Life Sci."},{"key":"10.1016\/j.exger.2019.110766_bb0160","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1089\/omi.2016.0106","article-title":"Metabolic biomarkers and neurodegeneration: a pathway enrichment analysis of Alzheimer\u2019s disease, Parkinson\u2019s disease, and amyotrophic lateral sclerosis","volume":"20","author":"Kori","year":"2016","journal-title":"Omics"},{"key":"10.1016\/j.exger.2019.110766_bb0165","doi-asserted-by":"crossref","first-page":"6920","DOI":"10.1523\/JNEUROSCI.20-18-06920.2000","article-title":"Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity","volume":"20","author":"Kruman","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.exger.2019.110766_bb0170","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1159\/000007984","article-title":"Elevated plasma levels of homocysteine in Parkinson\u2019s disease","volume":"40","author":"Kuhn","year":"1998","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.exger.2019.110766_bb0180","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1212\/WNL.0000000000003663","article-title":"Metabolomic biomarkers as strong correlates of Parkinson disease progression","volume":"88","author":"LeWitt","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.exger.2019.110766_bb0185","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/B978-0-12-374105-9.00034-4","article-title":"Hoehn and Yahr staging scale","author":"Martinez-Martin","year":"2010","journal-title":"Encycl. Mov. Disord."},{"key":"10.1016\/j.exger.2019.110766_bb0190","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1002\/j.1460-2075.1993.tb05839.x","article-title":"Phosphatidylethanolamine is the donor of the terminal phosphoethanolamine group in trypanosome glycosylphosphatidylinositols","volume":"12","author":"Menon","year":"1993","journal-title":"EMBO J."},{"key":"10.1016\/j.exger.2019.110766_bb0195","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/4551054a","article-title":"Systems biology: metabonomics","volume":"455","author":"Nicholson","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.exger.2019.110766_bb0200","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/nrd1157","article-title":"Understanding \u201cglobal\u201d systems biology: metabonomics and the continuum of metabolism","volume":"2","author":"Nicholson","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.exger.2019.110766_bb0205","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1001\/archneur.61.6.865","article-title":"Elevated plasma homocysteine level in patients with Parkinson disease: motor, affective, and cognitive associations","volume":"61","author":"O\u2019Suilleabhain","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.exger.2019.110766_bb0210","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3390\/nu10040391","article-title":"Protein-amino acid metabolism disarrangements: the hidden enemy of chronic age-related conditions","volume":"10","author":"Pasini","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.exger.2019.110766_bb0215","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/4829180","article-title":"Ethanolamine and phosphatidylethanolamine: partners in health and disease","volume":"2017","author":"Patel","year":"2017","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.exger.2019.110766_bb0220","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.3390\/ijms20102373","article-title":"Mitochondrial-derived vesicles as candidate biomarkers in Parkinson\u2019s disease: rationale, design and methods of the EXosomes in PArkiNson Disease (EXPAND) study","volume":"20","author":"Picca","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.exger.2019.110766_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2019.110692","article-title":"The metabolomics side of frailty: toward personalized medicine for the aged","volume":"126","author":"Picca","year":"2019","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.exger.2019.110766_bb0230","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.parkreldis.2019.06.003","article-title":"Dysbiosis of gut microbiota in a selected population of Parkinson's patients","volume":"65","author":"Pietrucci","year":"2019","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.exger.2019.110766_bb0235","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1001\/archneur.60.1.59","article-title":"Elevated plasma homocysteine levels in patients treated with levodopa: association with vascular disease","volume":"60","author":"Rogers","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.exger.2019.110766_bb0240","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1073\/pnas.0610204104","article-title":"Molecular markers of early Parkinson\u2019s disease based on gene expression in blood","volume":"104","author":"Scherzer","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.exger.2019.110766_bb0245","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1016\/S0006-3495(97)78336-X","article-title":"The mechanism of lamellar-to-inverted hexagonal phase transitions in phosphatidylethanolamine: implications for membrane fusion mechanisms","volume":"73","author":"Siegel","year":"1997","journal-title":"Biophys. J."},{"key":"10.1016\/j.exger.2019.110766_bb0250","series-title":"Pattern Recognition in Practice","first-page":"461","article-title":"PLS discriminant plots","author":"Sj\u00f6str\u00f6m","year":"1986"},{"key":"10.1016\/j.exger.2019.110766_bb0255","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.aca.2007.04.043","article-title":"Assessing the statistical validity of proteomics based biomarkers","volume":"592","author":"Smit","year":"2007","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.exger.2019.110766_bb0260","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11306-011-0330-3","article-title":"Double-check: validation of diagnostic statistics for PLS-DA models in metabolomics studies","volume":"8","author":"Szyma\u0144ska","year":"2012","journal-title":"Metabolomics"},{"key":"10.1016\/j.exger.2019.110766_bb0265","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1074\/jbc.M112.434183","article-title":"Phosphatidylethanolamine deficiency in mammalian mitochondria impairs oxidative phosphorylation and alters mitochondrial morphology","volume":"288","author":"Tasseva","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.exger.2019.110766_bb0270","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1002\/mds.23429","article-title":"Systematic review of levodopa dose equivalency reporting in Parkinson\u2019s disease","volume":"25","author":"Tomlinson","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.exger.2019.110766_bb0275","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1194\/jlr.R700020-JLR200","article-title":"Phosphatidylserine and phosphatidylethanolamine in mammalian cells: two metabolically related aminophospholipids","volume":"49","author":"Vance","year":"2008","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.exger.2019.110766_bb0280","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.mcn.2019.06.003","article-title":"1H NMR profiling of the 6-OHDA parkinsonian rat brain reveals metabolic alterations and signs of recovery after N-acetylcysteine treatment","volume":"98","author":"Virel","year":"2019","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.exger.2019.110766_bb0285","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11306-007-0099-6","article-title":"Assessment of PLSDA cross validation","volume":"4","author":"Westerhuis","year":"2008","journal-title":"Metabolomics"},{"key":"10.1016\/j.exger.2019.110766_bb0290","doi-asserted-by":"crossref","first-page":"946","DOI":"10.3389\/fneur.2018.00946","article-title":"The peripheral inflammatory response to alpha-synuclein and endotoxin in Parkinson\u2019s disease","volume":"9","author":"White","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.exger.2019.110766_bb0295","series-title":"Matrix Pencils: Proceedings of a Conference Held at Pite Havsbad, Sweden","first-page":"286","article-title":"The multivariate calibration problem in chemistry solved by the PLS method","author":"Wold","year":"1983"},{"key":"10.1016\/j.exger.2019.110766_bb0300","series-title":"3D QSAR in Drug Design: Theory, Methods and Applications","first-page":"523","article-title":"PLS: partial least squares projections to latent structures","author":"Wold","year":"1993"},{"key":"10.1016\/j.exger.2019.110766_bb5000","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects","volume":"310","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.exger.2019.110766_bb0305","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00441-018-2813-2","article-title":"Molecular basis of dopamine replacement therapy and its side effects in Parkinson\u2019s disease","volume":"373","author":"You","year":"2018","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.exger.2019.110766_bb0310","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1515\/CCLM.2005.193","article-title":"Plasma homocysteine levels in L-dopa-treated Parkinson\u2019s disease patients with cognitive dysfunctions","volume":"43","author":"Zoccolella","year":"2005","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.exger.2019.110766_bb0315","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2174\/157016106777698414","article-title":"Hyperhomocysteinemia in movement disorders: current evidence and hypotheses","volume":"4","author":"Zoccolella","year":"2006","journal-title":"Curr. Vasc. Pharmacol."}],"container-title":["Experimental Gerontology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0531556519305765?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0531556519305765?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T02:48:24Z","timestamp":1759978104000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0531556519305765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":64,"alternative-id":["S0531556519305765"],"URL":"https:\/\/doi.org\/10.1016\/j.exger.2019.110766","relation":{},"ISSN":["0531-5565"],"issn-type":[{"value":"0531-5565","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating amino acid signature in older people with Parkinson's disease: A metabolic complement to the EXosomes in PArkiNson Disease (EXPAND) study","name":"articletitle","label":"Article Title"},{"value":"Experimental Gerontology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exger.2019.110766","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110766"}}